Abstract
Growth hormone has been available for treatment of various conditions for over 50 years. There have been a number of chronic disease states in which it has been used, such as chronic kidney disease, which became a US Food and Drug Administration (FDA)-approved indication in 1993. For other chronic disease states there have been clinical studies supporting its use, but they have not yet been approved as a indications by the FDA. Examples of such diseases are cystic fibrosis, chronic arthritis, short bowel syndrome, burn trauma, and hypophosphatemic rickets.
| Original language | English |
|---|---|
| Pages (from-to) | 747-759 |
| Number of pages | 13 |
| Journal | Endocrinology and Metabolism Clinics of North America |
| Volume | 41 |
| Issue number | 4 |
| DOIs | |
| State | Published - Dec 2012 |
Keywords
- Burns
- Chronic inflammation
- Chronic kidney disease
- Cystic fibrosis
- Growth hormone
- Short bowel syndrome
- Short stature
ASJC Scopus subject areas
- Endocrinology, Diabetes and Metabolism
- Endocrinology
